Hidradenitis Suppurativa Clinical Trials
Hidradenitis Suppurativa clinical trials study new biologics, small-molecule drugs, and treatment approaches for hidradenitis Suppurativa and related immune or inflammatory conditions. Corterve gathers actively recruiting Hidradenitis Suppurativa studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Hidradenitis Suppurativa studies
- A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF TherapyNCT05889182PHASE3AbbVieBirmingham, Alabama
- Rollover Study for Participants Previously Enrolled in Clinical Trials of PovorcitinibNCT06855498PHASE3Incyte CorporationBirmingham, Alabama
- Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaNCT07213973PHASE2Incyte CorporationBirmingham, Alabama
- A Study to Assess NAV-240 in Adult Participants With Hidradenitis SuppurativaNCT07384975PHASE2Navigator Medicines, Inc.Phoenix, Arizona
- Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis SuppurativaNCT07049575PHASE1Incyte CorporationPhoenix, Arizona
- Capsule Microbiota Transplant Therapy for Hidradenitis SuppurativaNCT06058520EARLY_PHASE1University of MinnesotaMinneapolis, Minnesota
- Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaNCT07170917PHASE2SanofiPhoenix, Arizona
- A Study of Zasocitinib in Adults With Hidradenitis SuppurativaNCT07244263PHASE2TakedaScottsdale, Arizona
- The Ohio State University Dermatology BiorepositoryNCT03146676Ohio State UniversityColumbus, Ohio
- Myriad™ Augmented Soft Tissue Reconstruction RegistryNCT05243966Aroa Biosurgery LimitedPhoenix, Arizona
- A Study Evaluating BFB759 in Moderate to Severe Hidradenitis SuppurativaNCT07287644PHASE2, PHASE3Bluefin Biomedicine, Inc.Phoenix, Arizona
- A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis SuppurativaNCT07077902PHASE2Tulane UniversityCovington, Louisiana
Hidradenitis Suppurativa trials by state
Hidradenitis Suppurativa trials by metro
Frequently asked questions
- How do I find recruiting Hidradenitis Suppurativa clinical trials?
- Corterve aggregates actively recruiting Hidradenitis Suppurativa studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Hidradenitis Suppurativa clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Hidradenitis Suppurativa clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.